The Information : Meta Looks to Charge Up to $200 a Month for Planned ‘Hatch’ AI

Meta Looks to Charge Up to $200 a Month for Planned ‘Hatch’ AI Agent

The Takeaway
  • Meta’s planned Hatch AI agent could cost up to $200 monthly, rivaling top AI subscriptions.
  • Hatch will create software tools and handle tasks such as managing schedules and sending emails for users.
  • A premium version of Hatch would be part of Meta’s efforts to diversify revenue beyond advertising.

Meta Platforms is considering charging up to $200 a month for its planned consumer version of the OpenClaw AI agent tool, according to internal documents, an ambitious target that would rival top tier offerings from established AI giants.

The product, currently called Hatch, could launch with tiered pricing including the $199.99 premium subscription that would include higher usage limits, according to the documents reviewed by The Information and a person familiar with the matter, who noted that final pricing decisions haven’t been made.

Hatch would handle a range of tasks from vibe coding new software tools to scheduling events on users’ calendars or sending emails on their behalf, according to images of test versions also viewed by The Information. Users can describe what they want in plain language, similar to the way vibe coding apps work, such as “build me a fitness tracker,” and Hatch generates a working tool.

Charging for a premium version of Hatch would place Meta in more direct competition with OpenAI, Anthropic and other AI firms that already have built large customer bases for their AI coding and agent products. Both OpenAI’s ChatGPT Pro subscription and the highest-end version of Anthropic’s Claude Max plan cost $200 per month.

As previously reported, Meta is conceiving of Hatch as essentially a consumer version of OpenClaw, the open-source agent tool that has become popular in tech circles but complicated to use. The planned product is part of Meta Chief Executive Mark Zuckerberg’s broader effort to develop new revenue streams to help pay for its enormous investments in AI infrastructure and model development.

The documents, which date from April and May, show that Hatch also includes a customizable feed or dashboard to display the tools created by the agent, similar to OpenClaw, which lets users pick from capabilities called “skills” where modular add-ons let AI agents access tools, automate workflows, and interact with third-party services. These skills will allow Hatch to carry out specific tasks, such as creating a travel itinerary, according to the person familiar with the matter.

Meta-Powered AI

In its development so far, Hatch has been powered by Anthropic’s Claude Opus 4.6 and Claude Sonnet 4.6 models. When launched, Hatch will be powered by Meta’s latest AI model, Muse Spark, the person said.

Upgrade to ask Deep Research to…
What risks surround SpaceX’s massive Anthropic deal?
What threatens startups using Anthropic and OpenAI?
What could derail the 2026 AI IPOs?
How are AI costs hurting SaaS vendors?
In an April internal memo, product marketing manager Jennifer Lin said Meta was working to expand the agentic capabilities of skills, but that no final decisions had been made on branding, and that the name “Meta AI Skills” had not been confirmed.

The internal documents indicate Meta was initially targeting a U.S. launch in April. A separate internal memo from early May said Meta was aiming for a controlled rollout to about 10 businesses to pilot the product, followed by a broader launch with finalized branding and product naming in July, although the launch date could change.

In one of the internal documents, Meta describes plans to launch a paid premium subscription tier, “Hatch Plus,” which would offer significantly higher usage limits than the free version—between five and ten times more daily capacity. The document also states that token allowances would reset each billing cycle and would not roll over, “similar to Claude, OpenAI, etc.”

Zuckerberg has said that Meta intends to build AI agents for business as well as individual users, whom he sees as central to his vision for what he calls personal superintelligence. “Our goal is not just to deliver Meta AI as an assistant, but to deliver agents that can understand your goals and then work day and night to help you achieve them,” he said in Meta’s second-quarter earnings call in April.

The Meta chief also dropped hints about users being able to vibe-code their own tools, saying that whether people use its personal or business agents to achieve their goals, he believes there will be a “massive increase in entrepreneurship from people creating new things that they’ve always wanted to exist but previously didn’t have the tools to bring into the world.”

Meta has increasingly focused on turning its AI investments into revenue-generating products as the company continues to invest heavily in infrastructure, chips, and model development. Its AI capabilities helped drive strong growth in 2025, when revenue topped $200 billion. But almost all of that still comes from advertising, and Meta is under investor pressure to add new revenue streams to justify its capital expenditures, which it has said could reach $145 billion this year, about double the level in 2025.

The company has already begun rolling out paid features for its AI offerings, including subscription plans tied to its Meta AI chatbot, which is accessible through Facebook, Instagram and WhatsApp. This week, Meta also said it is expanding existing AI agent tools that businesses can use within its platforms, extending its Meta Business Agent product to Instagram and launching Meta Business Agent Platform.

The agents in those tools can recommend products, close sales, book appointments, answer customer questions, and send personalized marketing messages, as well as provide business owners with overnight chat summaries and performance insights. The Meta Business Agent tools are currently free, and Meta said it plans to introduce paid subscriptions in the coming months. Those tools are intended for use on Meta’s own platforms, whereas Hatch will also be able to function in the wider digital world.

>>> Goldman Raises Kospi Target to 12000, Upgrades Taiwan to Overweight

Goldman Raises Kospi Target to 12000, Upgrades Taiwan to Overweight

Goldman Sachs raises its 12-month target for South Korea’s Kospi stock benchmark to 12000 from 9000 and upgrades Taiwan’s benchmark Taiex to overweight with a 51000 target. “We lean into north Asia where earnings growth is strongest,” GS analysts led by Timothy Moe say in a note, citing AI-driven surging profits in the tech-heavy markets. This year, the Kospi has more than doubled while the Taiex is up around 60%, they note. GS expects Korea to lead Asia with profit growth of 320% in 2026, followed by Taiwan at 48%. The bank cautions that recent market gains raise the risk of a correction, recommending derivative overlays to hedge against a possible sharp pullback.

>>> Abivax : Guggenheim Call - from X

https://x.com/seedy19tron/status/2062233372399632421?s=48&t=TyS9gd0pKsNaRNM_CyjCiA

team on the gugg fireside:

- part B will be released in the coming days, has an additional 400 + 200 (relapse) pt data which will further alleviate investor concerns re safety (all on drug no pbo)
- 2 yr rat carc data and 6 mo mouse data no signals , further evidence that there is no correlation , the only lesions (mostly rash) came up (none cancerous) at what would be the human equivalent of much much higher than 50mg exposure
- very confident no black box and don’t think warning either , cited other cases where the malignancies were similar or higher without a black box or even a warning
- part B presentation will also have an updated safety table from part A , where the malignancies will be updated to reflect the correct information
- meeting pre NDA scheduled
- looping in some seasoned FDA folk in gastro for guidance and help to get it right

There were other tidbits that can happily allow me to say that the market initial reaction got it completely wrong (mgmt also to an extent but it caught them completely off guard) but this provides a second generational opportunity with
$abvx

PoS for Crohns higher , no bb or even a warning (most likely scenario just fyi) this could do $10b in peak sales.

Also I actually think the setup to buy here is better than buying at $8 (knowing the blinded blended data) because we KNOW all things considered is the best oral in UC and the magnitude of effect means that it’s very likely it will be more than fine in CD as well.

To conclude my review of all evidence drives to only one conclusion Obe does not cause cancer or accelerate it. Today’s price action reflective of the narrative correcting and this only the beginning of the stock recovering to levels reflective of the unbelievable asset they own.

>>> Europe : Brokers Upgrades & Downgrades - 3rd of June 2026

>>> Up
* ASML PT Raised to 1,900 euros from 1,515 euros at JPMorgan
* Cranswick Raised to Outperform at BNP Paribas; PT 6,750 pence

>>> Down
* Chipotle Cut to Equal-Weight at Morgan Stanley; PT $37
* Herantis Pharma Cut to Reduce at Inderes; PT 2.20 euros
* Stroeer Cut to Sell at Goldman; PT 37 euros
* Thermo Fisher Cut to Hold at HSBC; PT $540
* Victoria's Secret Cut to Neutral at UBS; PT $90
* Victoria's Secret Cut to Hold at Jefferies; PT $73

>>> Initiation
* Douglas Rated New Buy at Berenberg; PT 16 euros
* FedEx Reinstated Buy at William O'Neil
* Hexatronic Rated New Neutral at SB1 Markets; PT 47 kronor
* Omnicom Reinstated Buy at Goldman; PT $146
* Publicis Reinstated Buy at Goldman; PT 110 euros
* RELX Reinstated Buy at Goldman; PT 3,000 pence
* WPP Reinstated Sell at Goldman; PT 240 pence

>>> Call
* ASML PT Lifted at JPMorgan, Street Estimates ‘Behind the Curve’
* Douglas Initiated Buy at Berenberg on Compelling Risk-Reward

>>> What to look at today - 3rd of June 2026

Global equities advanced to new highs as demand for artificial-intelligence stocks intensified, cementing the sector’s role as the market’s main driver. The yen hovered near 160 per dollar. MSCI’s All Country World Index rose 0.1% to a record, with gauges in Asia and the US setting all-time highs. Tokyo Electron Ltd. and Taiwan Semiconductor Manufacturing Co. climbed to new peaks after the Philadelphia Semiconductor Index rallied almost 6% to a record. South Korean markets were shut for a holiday. The tech sector remained a key focus, with SpaceX seeking $135 a share for a $75 billion initial public offering, according to Reuters. Futures contracts for the S&P 500 and the Nasdaq 100 were little changed. Even so, caution crept in as Brent crude rose for a third day on pessimism over the prospects of the US and Iran reaching a peace deal and as fresh fighting flared up in the Middle East. European equities were also set for a modest loss at the open. Investors piling into AI-linked stocks have propelled global equities to unprecedented levels. Traders have looked past concerns about elevated valuations, betting that strong earnings growth and easing geopolitical tensions will continue to support risk assets. President Donald Trump remained optimistic the US can reach an interim peace deal soon. He disputed reports in Iranian state media that said talks with Washington had been suspended over the fighting in Lebanon, saying the two sides have been “continuously” having conversations, including “today.” The yen was in focus as investors awaited Bank of Japan Governor Kazuo Ueda’s planned speech for clues on the outlook for interest rates. Traders are reluctant to push the yen beyond the key 160 level against the dollar in the face of the risk of intervention by authorities to prop up the currency. In other corners of the market, gold edged lower to about $4,480 an ounce as inflation worries fueled expectations that borrowing costs will stay elevated for longer. Bitcoin slid below $66,000.  Treasuries edged lower, with the yield on the 10-year bond rising one basis point to 4.45%. The first of three labor-market reports due this week reinforced wagers that the Federal Reserve’s next move will be to raise interest rates.  In tariff news, the US is proposing levies of at least 10% on imports from most major trading partners following an investigation into forced-labor practices, as Trump seeks to rebuild the sweeping tariff wall struck down by the US Supreme Court. Elsewhere, Cliffwater LLC’s flagship private credit fund capped redemptions at 5% in the second quarter after investors looked to pull about 17% of shares, in a sign of enduring pressure on the $1.8 trillion market. Meanwhile, tensions remained high in the Middle East as the US Central Command said forces defeated multiple Iranian ballistic missiles and drones, and conducted self-defense strikes on Qeshm Island in response to attempted attacks by Iran. Even as businesses navigated rising energy costs sparked by the Iran war, US job openings jumped in April to the highest level in almost two years and layoffs fell, adding to signs the labor market remains resilient. US After Hours GME +7.8%, PANW +2.3%, ULTA +0.8% higher on earnings; YEXT -13.8%, GTLB -6.9% lower on earnings.

Nikkei +3.01% Hang Seng -1.68% CSI +1.55% Kospi +0.15% Shanghai +0.56% Shenzen +1.38%

Eur$ 1.1625 CNH 6.7676 CNY 6.7676 JPY 159.89 GBP 1.3459 CHF 0.7885 RUB 73.2205 TRY 45.9505 WTI$ 94.96 +1.28% Gold 4,470 -0.47% BTC 66,300 -1.79% ETH 1,842 -3.27%

S&P -0.05% Nasdaq -0.06% EuroStoxx -0.23% FTSE -0.03% Dax -0.27% SMI -0.23%

Macro :
- US Proposes Broad Tariffs of at Least 10%, Citing Forced Labor
- Altman to Meet White House and Congress Officials, Politico Says

Keep an eye on :
- AF FP : Air France, KLM, Transavia Able to Maintain Flights This Summer
- Anthropic IPO : Microsoft targets Anthropic with new model releases
- ARGX BB : Argenx Presents New Efgartigimod Data in Myositis, Sjogren’s
- ATRLJB SS : Atrium Ljungberg Holder Varma Offers Shares, Atrium Ljungberg Offering by Holder Prices at SEK27.35/Share
- BAS GY : Carlyle Wins Condition EU Nod to Take Over BASF Coatings Unit
- BP/ LN : BP Held Advanced Talks With Ithaca on North Sea Assets: FT
- DDOG US : Datadog Shares Drop as Insider Sells $10 Million of Stock
- GEBN SW : Geberit to Repurchase up to CHF300m of Shares
- HGV US : Hilton Grand Vacations Holders Offer 5m Shares
- ITX SM : Inditex 1Q Ebit Margin Misses Estimates
- JNJ US : Johnson & Johnson’s Nipocalimab Met Primary Goal in Lupus Trial
- MGN NO : Magnora Data Center Places Shares, to Start Trading About June 8
- MRVL US : *MARVELL SHARES EXTEND POSTMARKET GAIN TO AS MUCH AS 9.4%
- MSFT US : Microsoft targets Anthropic with new model releases
- MSFT US : Nvidia Partners With Microsoft on Unified Stack for Agentic AI
- NKE US : Nike Shares Underperform as Steph Curry Signs With Li-Ning
- PGHN SW : Partners Group Gates Evergreen Fund as Redemption Requests Rise
- PRX NA : Prosus Gets Until Oct. 11 for Delivery Hero Sale After Uber Bid
- REFL NO : ReFuels Holder CNG Services Assets Considers Share Sale
- RYA LN : Ryanair May Load Factor 95%
- SPCX US : SpaceX Seeks $75 Billion in IPO at $135 Per Share: Reuters
- TSLA US : Tesla Sees Accelerating Sales Momentum, JPMorgan Says
- UCB BB : UCB: Bimzelx Improves Patient Reported Outcomes in PsA and AxSpA
- VOE AV : Voestalpine FY Ebit Beats Estimates, Voestalpine Overcomes Steel Tariffs to Beat Estimates
- WBD US : Webuild Joint Venture Wins $1 Billion Ohio River Tunnel Contract